Last10K.com

Therapy Cells Inc (TCEL) SEC Filing 8-K Material Event for the period ending Monday, September 30, 2019

Therapy Cells Inc

HISTORY TOOLS
CIK: 1429859 Ticker: TCEL

View differences made from one to another to evaluate Therapy Cells Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Therapy Cells Inc.

Continue

Assess how Therapy Cells Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Therapy Cells Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Therapy Cells Inc provided additional information to their SEC Filing as exhibits

Exhibit 10.1: Consulting Agreement
Ticker: TCEL
CIK: 1429859
Form Type: 8-K Corporate News
Accession Number: 0001683168-19-003201
Submitted to the SEC: Tue Oct 08 2019 1:52:18 PM EST
Accepted by the SEC: Tue Oct 08 2019
Period: Monday, September 30, 2019
Industry: Wholesale Jewelry Watches Precious Stones And Metals
Events:
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/tcel/0001683168-19-003201.htm